Furthermore, we found that in vivo treatment with a TRPC4 channel blocker or an inhibitor of CaMKII, an upstream protein kinase regulating TRPC4 expression, significantly decreased ZIKV infection-associated seizures and improved the survival of ZIKV-infected neonatal mice. This evidence concerns the gene TRPC4 and Zika virus infectious disease.